NCT01106417View on ClinicalTrials.gov

Safety and Efficacy Study of NeoFuse in Subjects Undergoing Multi-Level Anterior Cervical Discectomy and Fusion

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

May 31, 2012

Study Completion Date

March 31, 2013

Conditions
Cervical Degenerative Disc DiseaseDegenerative SpondylolisthesisSpinal Stenosis
Interventions
BIOLOGICAL

NeoFuse

Single Dose NeoFuse Surgical Implantation

DEVICE

MasterGraft Granules

Single Dose MaterGraft Granules Surgical Implantation

Trial Locations (2)

3050

Royal Melbourne Hospital, Melbourne

3168

Monash Medical Centre, Clayton

Sponsors

Lead Sponsor

Mesoblast, Ltd.
All Listed Sponsors
lead

Mesoblast, Ltd.

INDUSTRY